Johnson & Johnson (JNJ), the health-care company beset by product recalls the last two years, said it was asking retailers to return about 12 million bottles of Motrin over concerns the painkiller may dissolve too slowly. Tests of product samples showed some caplets may not dissolve as quickly as intended when near their expiration date, J&J’s McNeil Consumer Healthcare unit said in a statement on its website today. While consumers don’t have to return any bottles, it’s possible there may be “a delay in relief” after taking the drug, Bonnie Jacobs, a spokeswoman, said in a telephone interview. J&J is based in New Brunswick, New Jersey.
